Dihematoporphyrin ether en es it fr

Dihematoporphyrin ether Brand names, Dihematoporphyrin ether Analogs

Dihematoporphyrin ether Brand Names Mixture

  • No information avaliable

Dihematoporphyrin ether Chemical_Formula

C68H74N8O11

Dihematoporphyrin ether RX_link

http://www.rxlist.com/cgi/generic3/photofrin.htm

Dihematoporphyrin ether fda sheet

Dihematoporphyrin_ether FDA

Dihematoporphyrin ether msds (material safety sheet)

Dihematoporphyrin ether Synthesis Reference

No information avaliable

Dihematoporphyrin ether Molecular Weight

1179.36 g/mol

Dihematoporphyrin ether Melting Point

No information avaliable

Dihematoporphyrin ether H2O Solubility

No information avaliable

Dihematoporphyrin ether State

Solid

Dihematoporphyrin ether LogP

5.127

Dihematoporphyrin ether Dosage Forms

Powder for solution

Dihematoporphyrin ether Indication

Indicated in the treatment of esophageal cancer.

Dihematoporphyrin ether Pharmacology

Porfimer is a photosensitizing agent used in the photodynamic therapy (PDT) of tumors. Porfimer is indicated for the palliation of patients with completely obstructing esophageal cancer, or of patients with partially obstructing esophageal cancer who cannot be satisfactorily treated with Nd:YAG laser therapy, reduction of obstruction and palliation of symptoms in patients with completely or partially obstructing endobronchial nonsmall cell lung cancer (NSCLC), and the treatment of microinvasive endobronchial NSCLC in patients for whom surgery and radiotherapy are not indicated. The cytotoxic and antitumor actions of porfimer are light and oxygen dependent. Tumor selectivity in treatment occurs through a combination of selective retention of porfimer and selective delivery of light.

Dihematoporphyrin ether Absorption

No information avaliable

Dihematoporphyrin ether side effects and Toxicity

No information avaliable

Dihematoporphyrin ether Patient Information

No information avaliable

Dihematoporphyrin ether Organisms Affected

Humans and other mammals